Department of Epidemiology and Department of Immunology & Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, United States of America.
PLoS Pathog. 2012;8(11):e1002989. doi: 10.1371/journal.ppat.1002989. Epub 2012 Nov 8.
Antigenic variation to evade host immunity has long been assumed to be a driving force of diversifying selection in pathogens. Colonization by Streptococcus pneumoniae, which is central to the organism's transmission and therefore evolution, is limited by two arms of the immune system: antibody- and T cell- mediated immunity. In particular, the effector activity of CD4(+) T(H)17 cell mediated immunity has been shown to act in trans, clearing co-colonizing pneumococci that do not bear the relevant antigen. It is thus unclear whether T(H)17 cell immunity allows benefit of antigenic variation and contributes to diversifying selection. Here we show that antigen-specific CD4(+) T(H)17 cell immunity almost equally reduces colonization by both an antigen-positive strain and a co-colonized, antigen-negative strain in a mouse model of pneumococcal carriage, thus potentially minimizing the advantage of escape from this type of immunity. Using a proteomic screening approach, we identified a list of candidate human CD4(+) T(H)17 cell antigens. Using this list and a previously published list of pneumococcal Antibody antigens, we bioinformatically assessed the signals of diversifying selection among the identified antigens compared to non-antigens. We found that Antibody antigen genes were significantly more likely to be under diversifying selection than the T(H)17 cell antigen genes, which were indistinguishable from non-antigens. Within the Antibody antigens, epitopes recognized by human antibodies showed stronger evidence of diversifying selection. Taken together, the data suggest that T(H)17 cell-mediated immunity, one form of T cell immunity that is important to limit carriage of antigen-positive pneumococcus, favors little diversifying selection in the targeted antigen. The results could provide new insight into pneumococcal vaccine design.
逃避宿主免疫的抗原变异长期以来一直被认为是病原体多样化选择的驱动力。肺炎链球菌的定植受到免疫系统两个分支的限制:抗体和 T 细胞介导的免疫。特别是,CD4(+)T(H)17 细胞介导的效应活性已被证明具有转导作用,可清除不携带相关抗原的共定植肺炎球菌。因此,尚不清楚 T(H)17 细胞免疫是否允许抗原变异受益并有助于多样化选择。在这里,我们表明在肺炎球菌携带的小鼠模型中,抗原特异性 CD4(+)T(H)17 细胞免疫几乎同样减少了抗原阳性菌株和共定植的抗原阴性菌株的定植,从而潜在地最小化了逃避这种类型免疫的优势。使用蛋白质组筛选方法,我们鉴定了一组候选人类 CD4(+)T(H)17 细胞抗原。使用该列表和之前发表的肺炎球菌抗体抗原列表,我们通过生物信息学评估了与非抗原相比,鉴定的抗原中的多样化选择信号。我们发现,抗体抗原基因比 T(H)17 细胞抗原基因更有可能受到多样化选择,而 T(H)17 细胞抗原基因与非抗原基因无法区分。在抗体抗原中,人类抗体识别的表位显示出更强的多样化选择证据。综上所述,数据表明 T(H)17 细胞介导的免疫,作为限制携带抗原阳性肺炎球菌的一种重要 T 细胞免疫形式,有利于目标抗原的多样化选择很少。该结果可为肺炎球菌疫苗设计提供新的见解。